Dark Forest Capital Management’s AEON Biopharma AEON Stock Holding History

Dark Forest Capital Management’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,051	Closed	-$3.65M	–	1160
2022 Q4	$3.65M	Buy	5,051 +4,202	+495%	+$3.01M	0.9%	28
2022 Q3	$602K	Buy	849 +503	+145%	+$356K	0.1%	219
2022 Q2	$244K	Hold	346	–	–	0.05%	284
2022 Q1	$243K	Sell	346 -108	-24%	-$75.7K	0.06%	344
2021 Q4	$317K	Buy	+454	New	+$319K	0.12%	169

Other funds holding AEON

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

GCWM

Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

Dark Forest Capital Management's AEON Position: Q1 2023 in Review

Dark Forest Capital Management sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 5,051 shares — an estimated $3.65M sold.

Dark Forest Capital Management first reported a position in AEON in Q4 2021 and held it in 5 quarters. The position peaked at $3.65M in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

Dark Forest Capital Management reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
Dark Forest Capital Management sold 5,051 AEON Biopharma shares in Q1 2023, an estimated $3.65M.
Dark Forest Capital Management first reported a position in AEON Biopharma in Q4 2021 and held it in 5 quarters.
Dark Forest Capital Management's AEON Biopharma position peaked at $3.65M in Q4 2022.
21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.